chr13-99255010-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_001098200.2(GPR18):​c.863T>A​(p.Ile288Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)

Consequence

GPR18
NM_001098200.2 missense

Scores

6
7
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.95
Variant links:
Genes affected
GPR18 (HGNC:4472): (G protein-coupled receptor 18) Predicted to enable G protein-coupled receptor activity. Predicted to be involved in positive regulation of Rho protein signal transduction and positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway. Predicted to act upstream of or within T cell differentiation; negative regulation of leukocyte chemotaxis; and negative regulation of tumor necrosis factor production. Predicted to be located in plasma membrane. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
UBAC2 (HGNC:20486): (UBA domain containing 2) Involved in negative regulation of canonical Wnt signaling pathway and negative regulation of retrograde protein transport, ER to cytosol. Acts upstream of or within protein localization to endoplasmic reticulum. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.858

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GPR18NM_001098200.2 linkuse as main transcriptc.863T>A p.Ile288Asn missense_variant 2/2 ENST00000397470.5 NP_001091670.1 Q14330H9NIM1
UBAC2NM_001144072.2 linkuse as main transcriptc.389+10386A>T intron_variant ENST00000403766.8 NP_001137544.1 Q8NBM4-1A0A024RE02A8K2S7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GPR18ENST00000397470.5 linkuse as main transcriptc.863T>A p.Ile288Asn missense_variant 2/21 NM_001098200.2 ENSP00000380610.2 Q14330
UBAC2ENST00000403766.8 linkuse as main transcriptc.389+10386A>T intron_variant 2 NM_001144072.2 ENSP00000383911.3 Q8NBM4-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 07, 2024The c.863T>A (p.I288N) alteration is located in exon 3 (coding exon 1) of the GPR18 gene. This alteration results from a T to A substitution at nucleotide position 863, causing the isoleucine (I) at amino acid position 288 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.59
BayesDel_addAF
Uncertain
0.10
D
BayesDel_noAF
Benign
-0.090
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Benign
0.36
T;T;T
Eigen
Uncertain
0.63
Eigen_PC
Pathogenic
0.70
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.94
.;D;.
M_CAP
Benign
0.039
D
MetaRNN
Pathogenic
0.86
D;D;D
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.55
N;N;N
PrimateAI
Pathogenic
0.83
D
PROVEAN
Uncertain
-3.7
D;D;D
REVEL
Uncertain
0.33
Sift
Uncertain
0.0020
D;D;D
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
1.0
D;D;D
Vest4
0.90
MutPred
0.67
Gain of catalytic residue at Y287 (P = 0.0069);Gain of catalytic residue at Y287 (P = 0.0069);Gain of catalytic residue at Y287 (P = 0.0069);
MVP
0.73
MPC
0.57
ClinPred
0.98
D
GERP RS
6.0
Varity_R
0.74
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr13-99907264; API